Search

everythinglearnresearchcommunity

for

Search:↓

Topical alpha-terthienyl with UVA may safely treat psoriasis without cancer risk.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Topical tacalcitol ointment can help improve symptoms of EFFC.

Severe anti-TNF-α induced scalp eruptions often need stopping the drug and using systemic therapy to avoid scarring.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Isotretinoin is recommended for acne treatment as it is as effective as cyproterone compound.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Baricitinib shows promise for treating alopecia areata with mild side effects.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Ritlecitinib was generally well tolerated in children with alopecia areata.

The niosomes effectively target hair follicles for acne treatment.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.